Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy

Abstract Introduction We aimed to elucidate the prognostic value of tumor regression grade (TRG) combined with lymph node status compared with the 8th edition of the ypTNM staging system in patients with advanced esophageal squamous cell cancer (ESCC) after neoadjuvant chemoradiotherapy (nCRT). Meth...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Cancer Medicine
المؤلفون الرئيسيون:	Jae Kwang Yun, Youngwoong Kim, Geun Dong Lee, Sehoon Choi, Yong‐Hee Kim, Dong Kwan Kim, Seung‐Il Park, Hyeong Ryul Kim
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Wiley 2022-10-01
الموضوعات:	esophageal cancer esophageal surgery neoadjuvant induction therapy tumor regression grade
الوصول للمادة أونلاين:	https://doi.org/10.1002/cam4.4748

مواد مشابهة

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma
حسب: Hui‐Jiang Gao, وآخرون
منشور في: (2020-09-01)

Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study
حسب: Jiazhen Chen, وآخرون
منشور في: (2025-08-01)

A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma
حسب: Kazem Anvari, وآخرون
منشور في: (2015-01-01)

Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma
حسب: Jun-Peng Lin, وآخرون
منشور في: (2025-08-01)

Prognostic role of the pathological status following neoadjuvant chemoradiotherapy and surgery in esophageal squamous cell carcinoma
حسب: Xiaofeng Duan, وآخرون
منشور في: (2025-01-01)

Recurrence timing and patterns incorporating lymph node status after neoadjuvant chemoradiotherapy plus esophagectomy for esophageal squamous cell carcinoma
حسب: Guihong Liu, وآخرون
منشور في: (2024-03-01)

Neoadjuvant chemoimmunotherapy was associated with better short‐term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy
حسب: Xiaofeng Duan, وآخرون
منشور في: (2024-08-01)

Therapeutic Effect of Lymph Node Dissection After Neoadjuvant Chemoradiation Therapy Followed by Esophagectomy on Esophageal Squamous Cell Carcinoma Using the Efficacy Index
حسب: Jiyoun Park, وآخرون
منشور في: (2025-03-01)

Comparison of neoadjuvant chemotherapy or chemoradiotherapy plus immunotherapy for locally resectable esophageal squamous cell carcinoma
حسب: Guozhen Yang, وآخرون
منشور في: (2024-05-01)

Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis
حسب: Dong-Bin Wang, وآخرون
منشور في: (2016-01-01)

A propensity score‐matched comparison of neoadjuvant chemoradiotherapy with cisplatin‐5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study
حسب: Fatih Gürler, وآخرون
منشور في: (2024-07-01)

Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
حسب: Guihong Liu, وآخرون
منشور في: (2024-03-01)

Evaluation of survival and recurrence patterns in esophageal cancer patients with pathological response to neoadjuvant chemoradiotherapy
حسب: Ali Kermani, وآخرون
منشور في: (2020-01-01)

MR radiomics predicts pathological complete response of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a multicenter study
حسب: Yunsong Liu, وآخرون
منشور في: (2024-01-01)

Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
حسب: Lei Xu, وآخرون
منشور في: (2022-11-01)

A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
حسب: Ding T, وآخرون
منشور في: (2021-10-01)

Enhanced prognosis prediction model in esophageal cancer via lymph node assessment post-neoadjuvant
حسب: Yehan Zhou, وآخرون
منشور في: (2025-09-01)

Comparative study of neoadjuvant chemoradiotherapy, chemotherapy, and chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma
حسب: Likun Liu, وآخرون
منشور في: (2025-08-01)

The Comparative Effect of Definitive Chemoradiotherapy and Neoadjuvant Chemoradiotherapy Plus Surgery on One-Year Survival Rate of Esophageal Cancer Patients
حسب: Fatemeh Khanaki, وآخرون
منشور في: (2022-12-01)

Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma
حسب: Zhen Wang, وآخرون
منشور في: (2022-06-01)

Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
حسب: Wing-Keen Yap, وآخرون
منشور في: (2022-11-01)

Prognostic role of lymph node regression in patients with esophageal cancer undergoing neoadjuvant therapy
حسب: Pingrun Chen, وآخرون
منشور في: (2024-10-01)

Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinomaResearch in context
حسب: Jing Wen, وآخرون
منشور في: (2022-12-01)

Multimodality deep learning radiomics predicts pathological response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
حسب: Yunsong Liu, وآخرون
منشور في: (2024-11-01)

The Impact of Radiation to Epicardial Adipose Tissue on Prognosis of Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy and Esophagectomy
حسب: Hung-Chi Tai, وآخرون
منشور في: (2021-04-01)

Esophageal squamous cell carcinoma with EP300 mutations displays distinct genetic characteristics relevant to neoadjuvant chemoradiotherapy
حسب: Yutian Lai, وآخرون
منشور في: (2025-01-01)

Comparison of neoadjuvant chemoradiotherapy versus chemoradiotherapy plus immunotherapy for esophageal squamous cell carcinoma in a real-world multicenter cohort: a propensity score matching study
حسب: Shuming Shi, وآخرون
منشور في: (2024-10-01)

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for stage II–IVa esophageal cancer: a network meta-analysis
حسب: Mingxing Wang, وآخرون
منشور في: (2025-01-01)

Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study)
حسب: Hai-Yu Zhou, وآخرون
منشور في: (2020-07-01)

Quantifying CD73 expression after chemotherapy or chemoradiotherapy in esophageal squamous cell carcinoma
حسب: Zachary A. Cooper, وآخرون
منشور في: (2025-03-01)

Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study
حسب: Zhao J, وآخرون
منشور في: (2023-08-01)

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
حسب: Weiming Han, وآخرون
منشور في: (2022-11-01)

Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
حسب: Canjun Li, وآخرون
منشور في: (2025-04-01)

The Effect of Neoadjuvant Therapy on Early Complications of Esophageal Cancer Surgery
حسب: Mohammadtaghi Rajabi Mashhadi, وآخرون
منشور في: (2015-07-01)

Predicting anastomotic leak in patients with esophageal squamous cell cancer treated with neoadjuvant chemoradiotherapy using a nomogram based on CT radiomic and clinicopathologic factors
حسب: Junfeng Zhao, وآخرون
منشور في: (2025-03-01)

PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus
حسب: Matteo Fassan, وآخرون
منشور في: (2019-10-01)

Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
حسب: Meng Zhang, وآخرون
منشور في: (2024-06-01)

Nomogram constructed by immunological and inflammatory indicators for predicting prognosis of patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy plus surgery
حسب: Yun Luo, وآخرون
منشور في: (2022-07-01)

Case report: A case study of neoadjuvant immunochemotherapy for locally advanced esophageal squamous carcinoma
حسب: Xiong Liu, وآخرون
منشور في: (2024-07-01)

Preliminary study on involving field irradiation radiotherapy in neoadjuvant chemoradiotherapy for esophageal cancer
حسب: DONG Xiaohuan, LIU Jun, LI Hongxuan, CHENG Yan, LI Yue, YU Wen, CAI Xuwei, FU Xiaolong
منشور في: (2023-03-01)